EFTA01989563.pdf
👁 1
💬 0
📄 Extracted Text (248 words)
To: 'eeva ation mail.com[[email protected]: Jeeevacationggmall.comj
From:
Sent: Sun 10/21/2012 3:31:31 PM
Subject: Re:
Ok
Sent from my iPhone
On Oct 21, 2012, at 11:16 AM, J [email protected]> wrote:
We left my exercise belt , by a new one
Sent from my iPad
On Oct 21, 2012, at 10:59 AM, la wrote:
Thank ou I have also researched
It is a capsule with powder in that
burns but I will try.
Sent from my iPhone
On Oct 21, 2012, at 7:14 AM, Jeffrey Epstein <[email protected]> wrote:
Generalized Anxiety Disorder — It is generally agreed
that episodes of generalized anxiety disorder require
several months or longer of sustained pharmacological
therapy. Maintenance of efficacy in GAD was
demonstrated with Cymbalta as monotherapy. Cymbalta
should be administered in a dose range of 60-120 mg
once daily. Patients should be periodically reassessed to
determine the continued need for maintenance treatment
and the appropriate dose for such treatment [see Clinical
Studies (JA,2)].
***********************************************************
The information contained in this communication is
EFTA_R1_00481839
EFTA01989563
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00481840
EFTA01989564
ℹ️ Document Details
SHA-256
8366e289cb30f04fe340a91f24030c51c5345665d18d8bbf9e52a77beb15b3da
Bates Number
EFTA01989563
Dataset
DataSet-10
Type
document
Pages
2
💬 Comments 0